✦ LIBER ✦

Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia

✍ Scribed by Witte, Michael M.; Case, Michael G.; Schuh, Kory J.; Ascher-Svanum, Haya

Book ID: 118275749
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 217 KB
Volume: 28
Category: Article
ISSN: 0300-7995
DOI: 10.1185/03007995.2012.657300

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OLANZAPINE LONG-ACTING INJECTION: AN 8-W

OLANZAPINE LONG-ACTING INJECTION: AN 8-WEEK DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY IN ACUTELY-ILL PATIENTS WITH SCHIZOPHRENIA

✍ David McDonnell; John Lauriello; Tim Lambert; Scott Andersen; Daniel Lin; Hollan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Efficacy of olanzapine long-acting injec

Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data

✍ Holland C Detke, Fangyi Zhao, Michael M Witte 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 223 KB

Comparison of metabolic changes in patie

Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine

✍ David P. McDonnell; Ludmila A. Kryzhanovskaya; Fangyi Zhao; Holland C. Detke; Pe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

Metabolic changes were examined in patients with schizophrenia during treatment with either oral olanzapine or olanzapine long‐acting injection (LAI). Data were collected from patients who had been stabilized on oral olanzapine (10, 15, or 20 mg/day) for ≥4 weeks and then randomized to either contin

A pooled analysis of injection site-rela

A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection

✍ Atkins, Susan; Detke, Holland C; McDonnell, David P; Case, Michael G; Wang, Shuf 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 163 KB

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLA

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE LONG-ACTING INJECTION COMPARED WITH RISPERIDONE LONG-ACTING INJECTION IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY

✍ SM Carroll; N Jemiai; B Suter; P O'Donohoe; U Skjoldborg; J Moller; OK Kleivenes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PMH31 Cost-Effectiveness of Long-Acting

PMH31 Cost-Effectiveness of Long-Acting Olanzapine Versus Long-Acting Risperidone in Patients with Schizophrenia in Spain

✍ T. Dilla; P. O'Donohoe; J. Möller; M. Álvarez; J. Sacristán; L. San; M. Happich; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB